1. Home
  2. OR vs CAI Comparison

OR vs CAI Comparison

Compare OR & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OR

Osisko Gold Royalties Ltd

HOLD

Current Price

$34.59

Market Cap

7.4B

ML Signal

HOLD

CAI

Caris Life Sciences Inc. Common Stock

N/A

Current Price

$27.35

Market Cap

7.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OR
CAI
Founded
2014
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.2B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
OR
CAI
Price
$34.59
$27.35
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$36.25
$34.43
AVG Volume (30 Days)
778.7K
2.3M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
0.61%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$243,647,000.00
$649,062,000.00
Revenue This Year
$89.31
$77.69
Revenue Next Year
$31.35
$35.80
P/E Ratio
$44.35
N/A
Revenue Growth
33.28
112.02
52 Week Low
$17.55
$22.86
52 Week High
$42.25
$42.50

Technical Indicators

Market Signals
Indicator
OR
CAI
Relative Strength Index (RSI) 56.95 N/A
Support Level $33.53 N/A
Resistance Level $34.77 N/A
Average True Range (ATR) 0.99 0.00
MACD 0.20 0.00
Stochastic Oscillator 73.20 0.00

Price Performance

Historical Comparison
OR
CAI

About OR Osisko Gold Royalties Ltd

OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.

About CAI Caris Life Sciences Inc. Common Stock

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: